Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Bordetella bronchiseptica ATP synthase subunit b (atpF), partial CSB-YP753176BTY
CSB-EP753176BTY
CSB-BP753176BTY
CSB-MP753176BTY
CSB-EP753176BTY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bordetella bronchiseptica Glutamate--cysteine ligase (gshA), partial CSB-YP753177BTY
CSB-EP753177BTY
CSB-BP753177BTY
CSB-MP753177BTY
CSB-EP753177BTY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bordetella bronchiseptica UPF0102 protein BB4515 (BB4515) CSB-YP753178BTY
CSB-EP753178BTY
CSB-BP753178BTY
CSB-MP753178BTY
CSB-EP753178BTY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bordetella bronchiseptica Thiazole synthase (thiG) CSB-YP753179BTY
CSB-EP753179BTY
CSB-BP753179BTY
CSB-MP753179BTY
CSB-EP753179BTY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bordetella bronchiseptica Thiamine-phosphate synthase (thiE) CSB-YP753180BTY
CSB-EP753180BTY
CSB-BP753180BTY
CSB-MP753180BTY
CSB-EP753180BTY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bordetella bronchiseptica Glutamate--tRNA ligase (gltX) CSB-YP753181BTY
CSB-EP753181BTY
CSB-BP753181BTY
CSB-MP753181BTY
CSB-EP753181BTY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bordetella bronchiseptica Serine hydroxymethyltransferase 2 (glyA2) CSB-YP753182BTY
CSB-EP753182BTY
CSB-BP753182BTY
CSB-MP753182BTY
CSB-EP753182BTY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bordetella bronchiseptica RNA pyrophosphohydrolase (rppH) CSB-YP753183BTY
CSB-EP753183BTY
CSB-BP753183BTY
CSB-MP753183BTY
CSB-EP753183BTY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bordetella bronchiseptica Lipid A palmitoyltransferase PagP (pagP) CSB-YP753184BTY
CSB-EP753184BTY
CSB-BP753184BTY
CSB-MP753184BTY
CSB-EP753184BTY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bordetella bronchiseptica Chaperone surA (surA) CSB-YP753185BTY
CSB-EP753185BTY
CSB-BP753185BTY
CSB-MP753185BTY
CSB-EP753185BTY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bordetella bronchiseptica Probable septum site-determining protein MinC (minC) CSB-YP753186BTY
CSB-EP753186BTY
CSB-BP753186BTY
CSB-MP753186BTY
CSB-EP753186BTY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bordetella bronchiseptica UDP-N-acetylenolpyruvoylglucosamine reductase (murB) CSB-YP753187BTY
CSB-EP753187BTY
CSB-BP753187BTY
CSB-MP753187BTY
CSB-EP753187BTY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bordetella bronchiseptica Phosphoserine aminotransferase (serC) CSB-YP753188BTY
CSB-EP753188BTY
CSB-BP753188BTY
CSB-MP753188BTY
CSB-EP753188BTY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bordetella bronchiseptica Probable Fe (2+)-trafficking protein (BB3405) CSB-YP753189BTY
CSB-EP753189BTY
CSB-BP753189BTY
CSB-MP753189BTY
CSB-EP753189BTY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bordetella bronchiseptica UvrABC system protein C (uvrC), partial CSB-YP753190BTY
CSB-EP753190BTY
CSB-BP753190BTY
CSB-MP753190BTY
CSB-EP753190BTY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bordetella bronchiseptica Kynurenine formamidase (kynB) CSB-YP753191BTY
CSB-EP753191BTY
CSB-BP753191BTY
CSB-MP753191BTY
CSB-EP753191BTY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bordetella bronchiseptica Diaminobutyrate--2-oxoglutarate transaminase (ectB) CSB-YP753192BTY
CSB-EP753192BTY
CSB-BP753192BTY
CSB-MP753192BTY
CSB-EP753192BTY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bordetella bronchiseptica Valine--tRNA ligase (valS), partial CSB-YP753193BTY
CSB-EP753193BTY
CSB-BP753193BTY
CSB-MP753193BTY
CSB-EP753193BTY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bordetella bronchiseptica Protein hfq (hfq) CSB-YP753194BTY
CSB-EP753194BTY
CSB-BP753194BTY
CSB-MP753194BTY
CSB-EP753194BTY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bordetella bronchiseptica Probable tRNA threonylcarbamoyladenosine biosynthesis protein Gcp (gcp) CSB-YP753195BTY
CSB-EP753195BTY
CSB-BP753195BTY
CSB-MP753195BTY
CSB-EP753195BTY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://m.cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>